Cargando…
A nanocomplex that is both tumor cell-selective and cancer gene-specific for anaplastic large cell lymphoma
BACKGROUND: Many in vitro studies have demonstrated that silencing of cancerous genes by siRNAs is a potential therapeutic approach for blocking tumor growth. However, siRNAs are not cell type-selective, cannot specifically target tumor cells, and therefore have limited in vivo application for siRNA...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045295/ https://www.ncbi.nlm.nih.gov/pubmed/21281497 http://dx.doi.org/10.1186/1477-3155-9-2 |